Literature DB >> 32499047

The Evolution-Driven Signature of Parkinson's Disease.

Nico J Diederich1, Toshiki Uchihara2, Sten Grillner3, Christopher G Goetz4.   

Abstract

In this review, we approach Parkinson's disease (PD) in the context of an evolutionary mismatch of central nervous system functions. The neurons at risk have hyperbranched axons, extensive transmitter release sites, display spontaneous spiking, and elevated mitochondrial stress. They function in networks largely unchanged throughout vertebrate evolution, but now connecting to the expanded human cortex. Their breakdown is favoured by longevity. At the cellular level, mitochondrial dysfunction starts at the synapses, then involves axons and cell bodies. At the behavioural level, network dysfunctions provoke the core motor syndrome of parkinsonism including freezing and failed gait automatization, and non-motor deficits including inactive blindsight and autonomic dysregulation. The proposed evolutionary re-interpretation of PD-prone cellular phenotypes and of prototypical clinical symptoms allows a new conceptual framework for future research.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; human evolution; mitochondria; pacemaker cells

Year:  2020        PMID: 32499047     DOI: 10.1016/j.tins.2020.05.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  7 in total

Review 1.  Mesenchymal stem cells for the treatment of cognitive impairment caused by neurological diseases.

Authors:  Mingcui Qu; Fei Xing; Na Xing
Journal:  Biotechnol Lett       Date:  2022-07-09       Impact factor: 2.716

Review 2.  Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hirohisa Watanabe; Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

Review 3.  The Dopaminergic Control of Movement-Evolutionary Considerations.

Authors:  Juan Pérez-Fernández; Marta Barandela; Cecilia Jiménez-López
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

4.  Connectivity impairment of cerebellar and sensorimotor connector hubs in Parkinson's disease.

Authors:  Epifanio Bagarinao; Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Reiko Ohdake; Aya Ogura; Michihito Masuda; Toshiyasu Kato; Satoshi Maesawa; Masahisa Katsuno; Gen Sobue
Journal:  Brain Commun       Date:  2022-08-20

5.  Effect of Scalp Nerve Block Combined with Intercostal Nerve Block on the Quality of Recovery in Patients with Parkinson's Disease after Deep Brain Stimulation: Protocol for a Randomized Controlled Trial.

Authors:  Ying Sheng; Hui Wang; Xinning Chang; Peipei Jin; Shengwei Lin; Shuang Qian; Jian Xie; Wenbin Lu; Xiya Yu
Journal:  Brain Sci       Date:  2022-07-29

6.  Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.

Authors:  Jie Sun; Chao He; Qiu-Xin Yan; Hong-Dan Wang; Ke-Xin Li; Xun Sun; Yan Feng; Rong-Rong Zha; Chang-Peng Cui; Xue Xiong; Shan Gao; Xue Wang; Rui-Xue Yin; Guo-Fen Qiao; Bai-Yan Li
Journal:  CNS Neurosci Ther       Date:  2021-01-21       Impact factor: 5.243

7.  Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.

Authors:  Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi
Journal:  Mov Disord       Date:  2021-08-24       Impact factor: 9.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.